Literature DB >> 31889357

Evaluation of a telehealth solution developed to improve follow-up after kidney Transplantation.

Charlotte Nielsen1,2, Hanne Agerskov1,2, Claus Bistrup1,2, Jane Clemensen2,3,4.   

Abstract

AIM: To explore patients' and healthcare professionals' experiences of using a telehealth solution developed to improve follow-up after kidney transplantation.
BACKGROUND: Transplantation is the treatment of choice whenever feasible for patients with end-stage kidney disease. However, it implies lifelong adherence of self-monitoring, medicine and other restrictions to ensure successful outcomes. Based on user involvement, a telehealth solution was developed to support patients and healthcare professionals post-transplantation.
DESIGN: An explorative qualitative study with a phenomenological-hermeneutic approach.
METHODS: The developed app and workflow for follow-up were tested by patients and healthcare professionals and evaluated with interviews. In total, 16 patients and 20 healthcare professionals participated. Individual interviews were conducted with the patients, four nurses participated in two sets of interviews, and 16 doctors participated in a focus group. Data were analysed with inspiration from Ricoeur's theory of interpretation, on three levels: Naïve reading, structural analysis and critical interpretation and discussion. The COREQ checklist was applied in reporting the study.
RESULTS: Three themes emerged: Challenging conditions for training sessions, telehealth improves patient reflection and collaboration, and telehealth gives patients a voice in consultations. In a challenging time, post-transplantation patients found the app easy to use; it facilitated support and reflection on how to manage. It also supported both patients and healthcare professionals at follow-up consultations in terms of enhanced preparation, improved dialogue and enabling consultations by phone.
CONCLUSION: The study showed that patients and healthcare professionals found the app and workflow valuable and easy to use. The Patient Data feature in the app has potential as a communication tool. However, adjustments and further investigations are needed to develop the solution. RELEVANCE TO CLINICAL PRACTICE: The potential of telehealth brings new opportunities to provide treatment and care to newly transplanted patients. Telehealth can support both patients and health professionals by improving dialogue and collaboration.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  patient experiences; qualitative study; renal nursing; technology; transplantation

Mesh:

Year:  2020        PMID: 31889357     DOI: 10.1111/jocn.15178

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  4 in total

Review 1.  Recommendations for the Design and Delivery of Transitions-Focused Digital Health Interventions: Rapid Review.

Authors:  Hardeep Singh; Terence Tang; Carolyn Steele Gray; Kristina Kokorelias; Rachel Thombs; Donna Plett; Matthew Heffernan; Carlotta M Jarach; Alana Armas; Susan Law; Heather V Cunningham; Jason Xin Nie; Moriah E Ellen; Kednapa Thavorn; Michelle LA Nelson
Journal:  JMIR Aging       Date:  2022-05-19

Review 2.  Acceleration of mobile health for monitoring post-transplant in the COVID-19 era: Applications for pediatric settings.

Authors:  Bianca R Campagna; Rebecca Tutino; Kristina Stevanovic; Julia Flood; Gali Halevi; Eyal Shemesh; Rachel A Annunziato
Journal:  Pediatr Transplant       Date:  2021-10-18

3.  Designing an App for Immunosuppression Adherence and Communication: A Qualitative Approach.

Authors:  Kara Schick-Makaroff; Laura Lagendyk; Bethany Foster; Ngan N Lam; Branko Braam; Aminu Bello; Soroush Shojai; Kevin Wen
Journal:  Can J Kidney Health Dis       Date:  2022-01-31

4.  Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience.

Authors:  Luigi Biancone; Enrico Minetti; Paride De Rosa; Paolo Rigotti; Giovanni Stallone; Marco Volpe; Franco Citterio
Journal:  J Nephrol       Date:  2022-02-17       Impact factor: 3.902

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.